German Pharmacies are calling for action due to antibiotic supply bottlenecks! Action Alliance for Patient Care in North Rhine (consisting of the Pharmacists’ Association, the General Practitioners’ Association, the Association of Medical Professions, and the Free Association of German Dentists) is indignant from the recent Federal Health Minister Karl Lauterbach’s denial that there are constant and new significant shortages of many life-saving medicines. The alliance says: “This is irresponsible and a slap in the face of the affected patients and the medical professions of doctors and pharmacists. Also, they stated that the supply crisis has so far only been avoided because the local doctors and pharmacies have worked hard during the period to search for the required medicines on the market and find a way to close the supply gaps with alternatives. This means many hours of additional work, for which they are not additionally paid.
The Alliance also demands the federal government to ensure stricter control on the medicine manufacturers which are mainly responsible for the regular and sufficient drug supplies. After all, there is also a social liability they need to care about. “Manufacturers’ role is critical to ensuring reliable, safe and effective medical care.”
German Pharmacies have every right to ask the responsible parties to take action to resolve these bottlenecks. According to the information of Mr. Holger Seyfarth, the chairman of the Hessian Pharmacists’ Association (HAV), there is a shortage of as many as 2791 medicines. That means the medicine bottleneck situation may even be worse than officially announced by the Federal Health Government. In this list are antibiotics, antidepressants, asthma medications, insulin, heart and cancer drugs, and painkillers, and unfortunately the numbers are growing.
Source: Aktionsbündnis: Lauterbach leugnet Engpässe | APOTHEKE ADHOC (apotheke-adhoc.de)
Disclaimer:
As a service to our readers, MVS Pharma GmbH publishing provides access to our archived content library in our blog. Please note the date of the last review or update on all articles. No content on this site should ever be used as a substitute for direct medical advice from your doctor or other qualified clinician.
MVS Pharma GmbH will soon be launching an omega-3 dietary supplement onto the European market that has been developed for the highest quality standards in terms of oxidation avoidance and therefore greatest bioavailability. In addition, in vitro studies are currently underway at the University of Ulm, in which Professor Dr. Rüdiger Groß tested a patented mouth and nose spray (Virudol) that can eliminate various flu viruses based on natural substances. In addition, MVS has a wholesale license and has specialized in sourcing much-needed medicines such as Amoxicillin, Salbutamol, etc. from India through its local branch with a focus on local quality and safety testing, compliance with international GMP regulations and the highest quality level of user security (examples of local language brochures, identical units of measurement, batch control and full tracking, etc.).
